La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

VIB Vermögen Croissance future

Future contrôle des critères 0/6

Les bénéfices de VIB Vermögen devraient diminuer de 36.8% par an tandis que son chiffre d'affaires annuel devrait croître de 0.07% par an. Le BPA devrait croître de diminuer de 36.8% par an. Le rendement des capitaux propres devrait être 7% dans 3 ans.

Informations clés

-36.8%

Taux de croissance des bénéfices

-36.8%

Taux de croissance du BPA

Real Estate croissance des bénéfices	95.8%
Taux de croissance des recettes	0.07%
Rendement futur des capitaux propres	7.0%
Couverture par les analystes	Low
Dernière mise à jour	22 Aug 2024

Mises à jour récentes de la croissance future

VIB Vermögen AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Feb 18

Recent updates

VIB Vermögen AG (ETR:VIH1) Shares Could Be 43% Below Their Intrinsic Value Estimate

Mar 29

VIB Vermögen AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Feb 18

Is It Too Late To Consider Buying VIB Vermögen AG (ETR:VIH1)?

Feb 11

Is It Too Late To Consider Buying VIB Vermögen AG (ETR:VIH1)?

Sep 06

Is VIB Vermögen (ETR:VIH1) A Risky Investment?

Oct 15

VIB Vermögen (ETR:VIH1) Has Compensated Shareholders With A Respectable 100% Return On Their Investment

Mar 11

A Closer Look At VIB Vermögen AG's (ETR:VIH1) Impressive ROE

Feb 18

You Have To Love VIB Vermögen AG's (ETR:VIH1) Dividend

Jan 19

Here's What VIB Vermögen AG's (ETR:VIH1) Shareholder Ownership Structure Looks Like

Dec 25

Shareholders Of VIB Vermögen (ETR:VIH1) Must Be Happy With Their 94% Return

Dec 06

A Closer Look At VIB Vermögen AG's (ETR:VIH1) Impressive ROE

Nov 18

Prévisions de croissance des bénéfices et des revenus

XTRA:VIH1 - Estimations futures des analystes et données financières antérieures (EUR Millions )
Date	Recettes	Les revenus	Flux de trésorerie disponible	Cash from Op	Moy. Nombre d'analystes
12/31/2026	101	49	70	95	1
12/31/2025	92	42	111	97	1
12/31/2024	85	38	15	104	1
12/31/2023	103	130	75	75	N/A
9/30/2023	105	107	73	73	N/A
6/30/2023	108	84	71	71	N/A
3/31/2023	128	76	N/A	N/A	N/A
12/31/2022	128	54	68	68	N/A
9/30/2022	126	41	N/A	N/A	N/A
6/30/2022	126	49	74	74	N/A
3/31/2022	106	143	N/A	N/A	N/A
12/31/2021	102	30	75	75	N/A
9/30/2021	101	54	N/A	N/A	N/A
6/30/2021	98	53	69	71	N/A
3/31/2021	96	71	N/A	N/A	N/A
12/31/2020	94	66	64	65	N/A
9/30/2020	94	71	N/A	N/A	N/A
6/30/2020	93	67	64	64	N/A
3/31/2020	92	64	N/A	N/A	N/A
12/31/2019	91	63	69	69	N/A
9/30/2019	90	58	N/A	N/A	N/A
6/30/2019	89	60	67	67	N/A
3/31/2019	88	59	N/A	N/A	N/A
12/31/2018	87	58	61	61	N/A
9/30/2018	86	58	N/A	N/A	N/A
6/30/2018	85	53	61	61	N/A
3/31/2018	85	51	N/A	N/A	N/A
12/31/2017	84	52	59	59	N/A
9/30/2017	83	49	N/A	N/A	N/A
6/30/2017	82	50	N/A	57	N/A
3/31/2017	81	50	N/A	N/A	N/A
12/31/2016	80	47	N/A	58	N/A
9/30/2016	79	43	N/A	N/A	N/A
6/30/2016	78	44	N/A	56	N/A
3/31/2016	77	40	N/A	N/A	N/A
12/31/2015	75	40	N/A	54	N/A
9/30/2015	73	37	N/A	N/A	N/A
6/30/2015	72	32	N/A	N/A	N/A
3/31/2015	71	32	N/A	N/A	N/A
12/31/2014	70	31	N/A	48	N/A
9/30/2014	69	29	N/A	N/A	N/A
6/30/2014	68	28	N/A	N/A	N/A
3/31/2014	66	27	N/A	N/A	N/A
12/31/2013	65	27	N/A	48	N/A
9/30/2013	64	25	N/A	N/A	N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: Les bénéfices de VIH1 devraient diminuer au cours des 3 prochaines années ( -36.8% par an).

Bénéfices vs marché: Les bénéfices de VIH1 devraient diminuer au cours des 3 prochaines années ( -36.8% par an).

Croissance élevée des bénéfices: Les bénéfices de VIH1 devraient baisser au cours des trois prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de VIH1 ( 0.07% par an) devrait croître plus lentement que le marché de German ( 5.2% par an).

Croissance élevée des revenus: Le chiffre d'affaires de VIH1 ( 0.07% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de VIH1 devrait être faible dans 3 ans ( 7 %).

VIB Vermögen Croissance future

Future contrôle des critères 0/6

Informations clés

Mises à jour récentes de la croissance future

Price target decreased by 33% to €29.00

VIB Vermögen AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

VIB Vermögen AG Provides Earnings Guidance for the Year 2022

Price target decreased to €49.98

Consensus forecasts updated

Consensus forecasts updated

Recent updates

VIB Vermögen AG, Annual General Meeting, Aug 14, 2024

VIB Vermögen AG to Report First Half, 2024 Results on Aug 27, 2024

Now 31% undervalued after recent price drop

Now 22% undervalued

New major risk - Revenue and earnings growth

Concerns Surrounding VIB Vermögen's (ETR:VIH1) Performance

Full year 2023 earnings released: EPS: €3.92 (vs €1.90 in FY 2022)

Investor sentiment improves as stock rises 16%

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 17%

New minor risk - Financial data availability

VIB Vermögen AG, Annual General Meeting, Jul 11, 2024

New major risk - Financial data availability

When Should You Buy VIB Vermögen AG (ETR:VIH1)?

Price target decreased by 33% to €29.00

VIB Vermögen AG to Report Fiscal Year 2023 Results on Mar 19, 2024

New major risk - Revenue and earnings growth

New minor risk - Earnings quality

First half 2023 earnings released

Is VIB Vermögen (ETR:VIH1) Using Too Much Debt?

VIB Vermögen AG to Report First Half, 2023 Results on Aug 03, 2023

Is Now The Time To Look At Buying VIB Vermögen AG (ETR:VIH1)?

VIB Vermögen AG (ETR:VIH1) Shares Could Be 43% Below Their Intrinsic Value Estimate

VIB Vermögen AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Full year 2022 earnings: EPS and revenues miss analyst expectations

Investor sentiment deteriorates as stock falls 18%

Is It Too Late To Consider Buying VIB Vermögen AG (ETR:VIH1)?

Is It Too Late To Consider Buying VIB Vermögen AG (ETR:VIH1)?

VIB Vermögen AG Approves Distribute Dividend

Upcoming dividend of €0.85 per share

Second quarter 2022 earnings released

VIB Vermögen AG Provides Earnings Guidance for the Year 2022

VIB Vermögen Ag Announces Executive Changes, October 1, 2022

Upcoming dividend of €0.85 per share

Price target decreased to €49.98

Consensus forecasts updated

Consensus forecasts updated

Full year 2021 earnings: EPS misses analyst expectations

VIB Vermögen AG Confirms Earnings Guidance for the Year 2022

VIB Vermögen AG Proposes Dividend

VIB Vermögen AG Starts Marketing the 'Next Horizon' Development Project with Around 79,000 Sqm of Commercial Space in Erding

DIC Asset AG (XTRA:DIC) cancelled the acquisition of additional 40.95% stake in VIB Vermögen AG (XTRA:VIH1).

Price target increased to €44.00

Consensus forecasts updated

Price target increased to €40.17

Third quarter 2021 earnings released: EPS €0.65 (vs €0.61 in 3Q 2020)

Price target increased to €38.08

Is VIB Vermögen (ETR:VIH1) A Risky Investment?

Second quarter 2021 earnings released

Supervisory Board Member Rolf Klug has left the company

Supervisory Board Member Franz-Xaver Schmidbauer has left the company

Upcoming dividend of €0.75 per share

Price target increased to €35.10

Consensus forecasts updated

Full year 2020 earnings released: EPS €2.39 (vs €2.29 in FY 2019)

Consensus forecasts updated

VIB Vermögen AG Provides Earnings Guidance for the Full Year of Fiscal 2021

VIB Vermögen (ETR:VIH1) Has Compensated Shareholders With A Respectable 100% Return On Their Investment

A Closer Look At VIB Vermögen AG's (ETR:VIH1) Impressive ROE

VIB Vermögen AG Provides Space for New Vaccination Centre in Ingolstadt

You Have To Love VIB Vermögen AG's (ETR:VIH1) Dividend

Here's What VIB Vermögen AG's (ETR:VIH1) Shareholder Ownership Structure Looks Like

VIB Vermögen AG Completes In-House Development in the Company's History with A Lettable Area of 115,000 Square Meters in the Interpark Near Ingolstadt on Schedule

Shareholders Of VIB Vermögen (ETR:VIH1) Must Be Happy With Their 94% Return

A Closer Look At VIB Vermögen AG's (ETR:VIH1) Impressive ROE

Third quarter 2020 earnings released: EPS €0.61

New 90-day low: €26.15

New 90-day high: €29.55

New 90-day low: €26.50